DSCSA 2023 stabilization period—what it means for compliance

The FDA has made the decision to establish a “stabilization period” for the DSCSA implementation. This timely webinar will look at what this means for the industry and investigate the possible gaps that created the need for an enforcement delay. Systech’s Steve Tallant will be joined by industry experts as he moderates a lively discussion on this critical issue for all the stakeholders in the pharmaceutical industry.

We’ll discuss these topics and more:

• The DSCSA deadline… Is it 2023 or 2024?
• How stable and tested are your data connections?
• Misalignment exceptions – what’s the plan?
• What gaps do you see?